Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors

被引:90
作者
Birindelli, S
Perrone, F
Oggionni, M
Lavarino, C
Pasini, B
Vergani, B
Ranzani, GN
Pierotti, MA
Pilotti, S
机构
[1] Ist Nazl Studio & Cura Tumori, Unita Anat, Pathol & Cytopathol Unit, I-20133 Milan, Italy
[2] Ist Nazl Studio & Cura Tumori, Prevent Med Unit, I-20133 Milan, Italy
[3] Ist Nazl Studio & Cura Tumori, Dept Expt Oncol, I-20133 Milan, Italy
[4] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy
关键词
D O I
10.1038/labinvest.3780293
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Karyotypic complexities associated with frequent loss or rearrangement of a number of chromosome arms, deletions, and mutations affecting the TP53 region, and molecular alterations of the INK4A gene have been reported in sporadic and/or neurofibromatosis type I (NF1)-related malignant peripheral nerve sheath tumors (MPNSTs). However, no investigations addressing possible different pathogenetic pathways in sporadic and NF1-associated MPNSTs have been reported. This lack is unexpected because, despite similar morphologic and immunophenotypic features, NF1-related cases are, by definition, associated with NF1 gene defects. Thus, we investigated the occurrence of TP53 and p16(INK4A) gene deregulation and the presence of microsatellite alterations at markers located at 17p, 17q, 9p21, 22q, 11q, 1p, or 2q loci in MPNSTs and neurofibromas either related (14 cases) or unrelated (14 cases) to NF1. Our results indicate that, in MPNSTs, p16(INK4A) inactivation almost equally affects both groups. However, TP53 mutations and loss of heterozygosity involving the TP53 locus (43% Versus 9%), and p53 wild type overexpression, related or not to mdm2 overexpression (71% Versus 25%), seem to mainly be restricted to sporadic MPNSTs. In NF1-associated MPNSTs, our microsatellite results are consistent with the occurrence of somatic inactivation by loss of heterozygosity of the second NF1 allele.
引用
收藏
页码:833 / 844
页数:12
相关论文
共 46 条
[1]   Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2 [J].
Abaza, MM ;
Makariou, E ;
Armstrong, M ;
Lalwani, AK .
LARYNGOSCOPE, 1996, 106 (06) :694-699
[2]  
Berner JM, 1999, GENE CHROMOSOME CANC, V26, P151, DOI 10.1002/(SICI)1098-2264(199910)26:2<151::AID-GCC7>3.3.CO
[3]  
2-1
[4]  
Birindelli S, 2000, INT J CANCER, V86, P255, DOI 10.1002/(SICI)1097-0215(20000415)86:2<255::AID-IJC16>3.0.CO
[5]  
2-L
[6]   Biochemical uncovering of mdm2/p53 complexes in liposarcomas parallels their immunohistochemical detection [J].
Butò, S ;
Pierotti, MA ;
Tamborini, E ;
Della Torre, G ;
Lavarino, C ;
Rilke, F ;
Pilotti, S .
DIAGNOSTIC MOLECULAR PATHOLOGY, 1999, 8 (03) :125-130
[7]   CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS [J].
CHO, YJ ;
GORINA, S ;
JEFFREY, PD ;
PAVLETICH, NP .
SCIENCE, 1994, 265 (5170) :346-355
[8]   Mouse models of tumor development in neurofibromatosis type 1 [J].
Cichowski, K ;
Shih, TS ;
Schmitt, E ;
Santiago, S ;
Reilly, K ;
McLaughlin, ME ;
Bronson, RT ;
Jacks, T .
SCIENCE, 1999, 286 (5447) :2172-2176
[9]   BENIGN NEUROFIBROMAS IN TYPE-1 NEUROFIBROMATOSIS (NF1) SHOW SOMATIC DELETIONS OF THE NF1 GENE [J].
COLMAN, SD ;
WILLIAMS, CA ;
WALLACE, MR .
NATURE GENETICS, 1995, 11 (01) :90-92
[10]   GENE P53 MUTATIONS ARE RESTRICTED TO POORLY DIFFERENTIATED AND UNDIFFERENTIATED CARCINOMAS OF THE THYROID-GLAND [J].
DONGHI, R ;
LONGONI, A ;
PILOTTI, S ;
MICHIELI, P ;
DELLAPORTA, G ;
PIEROTTI, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1753-1760